Congratulations to Dr. Kelsey Dean, who defended her dissertation on March 27th. We will miss her leadership in the lab but are excited to see where her career leads!
NIH funds closed loop in pregnancy studies at Harvard, Mt. Sinai, Mayo Clinic, and Sansum; three-year, $2.3 million grant
The NIH has awarded our group an R01 grant for the study of closed loop control of diabetes in pregnant women. The NIH has awarded our group an R01 grant for the study of closed loop control of diabetes in pregnant women
The results of our clinical trial are promising for the use of a phone app for diabetes management and have been featured in multiple news stories: Harvard Researchers Report Positive Trial Results with Artificial Pancreas Smartphone App “The results of a new clinical trial have shown the safety and efficacy of the interoperable Artificial […]
The Diabetes Research Group at the Harvard John A. Paulson School of Engineering and Applied Sciences is seeking post-doc fellows that would like to be engaged in cutting edge interdisciplinary biomedical research and the development of novel control algorithms to improve glucose control and quality of life for people with type 1 diabetes mellitus under […]
Jet Lag: Activating Neurons in the Brain Might be Key to Shifting Internal Clock, New Research Shows
Interrante, Abbey (2018). Newsweek. https://www.newsweek.com/jet-lag-summer-travel-1023064 This recent article in Newsweek highlights the work of one of our collaborators.
Dr. John Abel celebrates his PhD after being hooded by Dean Frank Doyle at Harvard’s 367th annual commencement. We are excited to see how his research continues to develop in his postdoctoral position working with Dr. Emory Brown at MIT.
Dr. John H. Abel defended his dissertation, entitled “A Computational Approach to Analysis and Control of the Mammalian Circadian Oscillator,” on April 5th. The Doyle group is excited to celebrate our newest Ph.D. and looks forward to seeing where his research career takes him!
A collaboration between the Doyle lab and Joslin Diabetes Center has resulted in a new technology for preventing hypoglycemic events following bariatric surgery. Read more within: EurekAlert